Fund Holdings — General Catalyst Group Management, LLC

Total Portfolio Value
$3.04B
Total Bought
$45.50M
Total Sold
$1.31B
Net Transaction
-$1.26B
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
FIGMA INC(FIG)0877,174+877,174045,4991.50%+45,499
MAZE THERAPEUTICS INC(MAZE)1,035,9101,035,910012,71126,8610.88%+14,151
GITLAB INC(GTLB)921,405921,405041,56541,5371.37%-28
FRACTYL HEALTH INC(GUTS)4,884,1934,884,19307,9127,7660.26%-147
VROOM INC(VRM)7,6290-7,6292180—-218
WAG GROUP CO6,976,5300-6,976,5301,6130—-1,613
ARRIVENT BIOPHARMA INC(AVBP)1,494,7861,494,786032,54127,5790.91%-4,963
MAPLEBEAR INC(CART)710,711710,711032,15326,1260.86%-6,027
OSCAR HEALTH INC(OSCR)2,107,7190-2,107,71945,1890—-45,189
SAMSARA INC(IOT)11,981,3319,250,880-2,730,451476,617344,59511.34%-132,022
CIRCLE INTERNET GROUP INC(CRCL)20,120,76919,001,041-1,119,7283,647,6942,519,15882.89%-1,128,536
Page 1 of 1
General Catalyst Group Management, LLC — 13F Holdings — Q3 2025 | TickerTrail